• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
12.04.2024
CarMax Is More Committed to Innovations But Market Conditions Make It Sinking

CarMax (KMX) quarterly report came out on April 11, vividly displaying why any immediate investment into the used car market still sounds like not a good idea. The stock quickly lost ground, wasting a double-digit number of percentage points as a response to its net income drop to $0.32 per share against $0.44 cents per share a year ago, also compared to much stronger $0.52, $0.75 and $1.44 per share in the previous three quarters. Analyst polls estimated a net income per share at about $0.50, which would be 56% better than the reality.

This almost looks like a financial fiasco in the company's efforts to withstand slowing demand in the segment. CarMax Q4 2023 revenue decreased by 1.7% to $5.6 billion, slightly below consensus expectations of $5.8 billion, indicating the lack of gross marginality of the business. This happened even though the total supply of unsold used vehicles on dealer lots grew by 9% YoY to 2.27 million units in March, according to Cox Automotive data. CarMax CEOs delayed their own goal of selling over 2 million units annually, when measuring combined retail and wholesale actions, to between 2026 and 2030, from its prior target of 2026.

A "higher-for-longer" Fed fund rates is demonstrably bad for car sales volumes, be it new generation Tesla cars or just pre-owned vehicles, while operating costs for warehouses are growing. Besides, easing some semiconductor constraints in North America may help marginally improving orders for new cars, leaving used-car sales under the same pressure. Meanwhile, the entrance of Asia players offered significant discounts. Therefore, North American and European operators of the used car market need to sell many great cars at cheaper prices. CarMax already posted its official warning of a potential "hit to profit-sharing revenue" due to inflationary impact to its partners, before last Christmas. "While affordability of used cars remains the challenge for consumers, pricing improved during the quarter," Enrique Mayor-Mora, executive vice president and CFO admitted.

It was only a smaller division of CarMax Auto Finance, which managed to get a 19% better income due to "a lower provision for loan losses" and an increase in average managed receivables. Yet, this was rather news from the side business, which was clearly not enough to be optimistic. The company added that it is now focused on enhancing its omni-channel experience and leveraging data science and automation. Carmax said it delivered "strong retail and wholesale" graphic processors, which helped to increase "used saleable inventory units" more than 10%, but used total inventory units was unchanged despite innovations. The company seeks to achieve efficiency improvements in its core operations, believing that they "are well-positioned to drive growth as the market turns", according to Enrique Mayor-Mora. This may be useful to strengthen competitiveness in better times for the segment. Yet, the current challenges are too heavy to be ignored by market crowds.

11.08.2022
Perspective Peers of Ethereum: Avalanche

Avalanche is ranked by Coinmarketcap at the 12th position by market cap with $7.8 billion, which is 4% less than Ethereum’s market cap. AVAX prices dropped by 82% of its peak values, allowing investors to buy it at early 2021 prices. Avalanche’s infrastructure consists of three logically isolated networks, each of these with their own processing, validators, and own set of rules.

This platform is often compared to the existing internet web infrastructure with core connection protocols like HTTP, surrounded by a huge number of networks to their apps. Avalanche allow for the creation of public and private systems as a blockchain or DAG (Directed Acyclic Graph) and for the use of different virtual machines for apps, including EVM engine (Ethereum Virtual Machine) that allows Enthereum network programs to be developed.

Avalanche includes C-chain to create smart contracts that are processed on an advanced EVM engine, P-Chain that coordinates validators that process transactions and also allows for the creation and management of new subnetworks, and X-Chain which is a directed acyclic graph regulating issuance and trade of cryptoassets. DAG systems record new transactions on top of the old ones, allowing for processing speed to be increased and for capacity substantially. It is quite different to other blockchains, where transactions are compiled in blocks in order to be processed.

The advantage of Avalanche is that it provides anyone with the opportunity to create his or her own isolated blockchain with its own set of parameters, including access to apps and the programming language with which it will work. Every subnetwork can process around 4,500 transactions per second compared to 14 processed by the Ethereum network.

26.11.2024
Meta Could Score 18% in the Next Few Months

Meta Platforms (META), the parent company of Facebook and Instagram, has been trading sideways within the $550-600 range since late September, underperforming the tech-heavy Nasdaq 100 index, which has gained 6.0% during the same period.

While META shares remain within an ascending channel, they are currently resting at the support of the uptrend. Historically, each time the stock reached this level, it rebounded upwards by 15-18%. Consequently, the share price is likely to rise to $650-670 over the coming months. I plan to open a long trade at $550-570, targeting a potential upside of $185. A stop-loss could be placed below recent lows at $480.

15.09.2022
Safe Haven Assets for Long-Term Investments: Broadcom

Broadcom is an American semiconductor and infrastructure software development company. Soon it is expected to close a merger deal with VMware, a cloud computing and visualization company, that will open new cross-sales opportunities for Broadcom to boost its revenues. Broadcom stocks are now 25% off their peak values.

According to the Q3 FY 2022 financial report that ended July 31, consolidated revenues grew by 25% year-over-year to $8.46 billion, and EPS went up by 40% to $9.73 per share. The semiconductors segment, that added 32% year-over-year, was the primary driver for the company’s profit. The company’s free cash flows (FCF) topped $4.3 billion, allowing it to spend $1.7 billion on dividends and 1.5 billion on the shares repurchase program. The company is planning to continue spending at least 50% of FCF on dividends that added 43% every year on average since 2016. 

According to the Q4 FY 2022 forward guidance, the company is expecting its revenues to go up by 20% year-over-year to $8.9 billion and for EDITDA to go up by 25% to $5.6 billion. Broadcom has great experience in expanding its product portfolio by M&A operations, and apparently it will continue on this way. The company is also expected to benefit greatly from the $52.7 billion CHIPS bill in the United States.


12.05.2022
Perspective ETFs in the ESG energy segment: Invesco Global Clean Energy Portfolio ETF

This ETF invests in green energy ventures. The pandemic led to a 300% increase of its share price. But since the beginning of 2022 they have lost 30%, twice as much as the S&P 500 SPY ETF. The net capital which has outflown from the Fund has reached $31.5 billion over the last 12 months, while the major outflow was recorded in December 2021. However, its shares are still seen to be overbought as P/E multiplier is at 24 that is well above the average of 20 for the EFT’s that are linked to the S&P 500, while the dividend yields are above PBD’s numbers.

Inflation in the United States is rising negatively affecting all shares with a high P/E ratio. So, we may expect a further decline of the PBD share price and other similar assets that cannot be protected from rising risks. Traditional energies are looking more attractive on this background and could be a perfect hedge asset amidst geopolitical uncertainties. 

How Deep Can Eli Lilly Sink?

One of the major pharmaceutical manufacturers in the world, which showed 10x growth in value for the last 5 years, dropped by double digit percentage this week. Eli Lilly lost more than $200 per share, or nearly 20% of its peaking market caps, compared to the company's all-time highs at $972.5 in August. This story gives us a tremendous opportunity to acquire a clearly attractive asset at a very good price. A fast bounce back to the northern border of the new range above $850, from the opening price below $800 on October 30 with local intraday dips detected at $769.75, freshly confirmed a flurry of interest among the investing crowd for a stronger recovery potential. At the same time, a wide daily range already in the first hours after Eli Lilly's earnings' report gives everyone additional time to choose a better price to enter the market, as we may expect more dips below $800 or even an attempt to slide further with an exclusively brief visit to the levels between $700 and $750, where risk-on strategies may even strengthen bullish positioning.

The reason behind Eli Lilly's sharp plunge was that its weight-loss drug sales substantially missed overly optimistic expectations. Analyst polls forecasted $4.20 billion for quarterly sales of diabetes treatment Mounjaro and $1.69 billion for Zepbound, which is another brand name for the same medication tirzepatide, regulatory approved for weight management in the U.S. and some other countries. Consensus saw the drug may provide the company with $19 billion of revenue before the end of this year. Now the market found that this would not happen, because sales of Mounjaro from July to September was $3.11 billion only, while sales of Zepbound were $1.26 billion. Of course, the firm posted EPS (earnings per share) of $1.18 only for Q3, failing much of the consensus at $1.45. Its total revenue came in at $11.44 billion instead of $12.09 billion, even though the number rose by 20% YoY.

Lilly commented this still reflected "continued strong demand", yet had to cut its full-year profit projection from the previous range between $16.10 and $16.60 per share to a much lower range between $13.02 and $13.52. Eli Lilly tried to reference $2.8 billion acquisition-related charges in the third quarter, yet also "higher manufacturing costs" was cited as well. The company kept the lower end for supposed sales range at $45.4 billion but lowered the upper end by $600 million to $46 billion.

As to the two tirzepatide-based drugs, Eli Lilly's CEO David Ricks admitted "there is an excess supply... but we haven't been stimulating demand the way we had originally planned," adding that his company delayed plans to advertise weight-loss drug Zepbound while also postponing international launches of production and distribution to focus on "increasing inventory levels in the U.S." Thus, sales of both Mounjaro and Zepbound "decreased by mid-single digits", derailed by "inventory changes" after Eli Lilly reportedly invested $7 billion in its Indiana site and facilities in Ireland to expand production. From our point of view, this may be a planning error that led to a partial deflation of a vast bubble of expectations, but it does not mean that the whole project was something like a big bubble. Discounting market price may reflect only a temporary and rather small trouble with marketing promotion plans for very popular new products, which are still in a bid demand. And so, a 20% or 25% correction of market value could be enough to revive the investment interest for the stock. Eventual recovery to the levels above $950 looks almost inevitable.

4669
AI Curse and Blessing

All eyes turn to the next $500 target when discussing Microsoft's ability to accelerate its long-term rally on markets. In this context, a moderate price gains were initially detected on Wednesday at the very first moment after announcing another historically record levels at $3.3 of quarterly profit per share on even better than expected 16% annual surplus in sales, also beating all-time highs at $65.6 billion from July to September vs the most encouraging peak at $64.7 billion in the previous quarter. Azure, Microsoft's cloud business, added 33% YoY above consensus estimates of around 32%. However, the company's own guidance for potentially slowing cloud business progress in the current quarter was a key to a nearly 4% drop in market values afterwards, so that immediate price corrections hit $415 per share in the pre-market trading activity on the last day of October, vs $432.50 as the last daily close before the news.

The unfortunate sentence by Microsoft chief financial officer Amy Hood, which a picky crowd didn't like, foresees fiscal second-quarter Azure revenue growth of 31% to 32%, instead of 32.25% expected on average by the Wall Street's pool of analysts, after it’s slowed from its maximum speed of 35% just one quarter before now. She added that the CapEx (capital expenditures), which already came at $20 billion per quarter, is going to expand more due to ongoing investments into building out more powerful data centres based on AI capacities. From our point of view, large cash investments to consolidate the clear success of Azure cloud division's closer partnership with ChatGPT-maker OpenAI seems justified as the entire pattern of previous expenditures of this kind has really paid off. Moreover, Microsoft is happily optimizing costs in other parts of its business, which is justified by an overall increase in marginality.

Therefore, we feel that a shy and jumpy wing of the market, fearing a decrease in Microsoft profits because of somewhat rising costs for artificial intelligence, which is undertaken by the flagship of the industry, is surely not the majority. All temporary price dips, which are still leading to a discounted value of the world's number one company in terms of market caps, will be repurchased very soon, if not during the next couple of weeks. The negative dynamics may be short-lived, even though the technical correction has some chance to retest a one-month low at $408.17 or even dive slightly below a two-month low at $400.80 under certain circumstances, as the move down may coincide with a wave of U.S. election vulnerability. In the same way, a part of investors was focused on elevated AI expenditures at Meta Platforms, when the Facebook father Mark Zuckerberg noted the spending was showing "strong momentum", when highlighting his brainchild's "significant" surge in capital investments in 2025 to run the wider and modernized AI infrastructure. Yet, we continue to believe in the new heights well above $600 for Meta, as well as returning to an uphill climb to the round figure of $500 by Microsoft.

4959
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
Monero Seen Up Soon

Monero (XMR) is down by 1.6% to $160.74, underperforming the broader crypto market, while Bitcoin (BTC) has gained 6.9% to $72,656. XMR's decline follows Kraken’s decision to delist the token for its European users, with any remaining XMR on the exchange set to be converted to Bitcoin at market rates by January 6.

This isn’t the first instance of Monero facing delistings, so there’s no immediate need to sell your XMR holdings. Price action shows signs of recovery, and a breakout from the current ascending triangle pattern could potentially drive prices 25-30% higher, signaling a promising rally ahead.

4945
B
Google Is On Track to Meet $200+ Targets

Like we've discussed many times before, Google was strongly undervalued, being probably the best AI technology integrator into the broadest range of search and video options, most popular among global customers' audience. Now is exactly the moment when any unbiased observer could watch the bullish momentum in Google stock is developing by seven-mile steps, meaning a 7% lump-sum run-up in its market value on Wednesday's pre-market. Current levels well above $180 is a good start for a new air of purpose about Google to drive it further on the road to $200 and then 10% to 15% higher. Stock analyst Brent Thill at Jefferies is talking about a "gem of a quarter" delivered by Google-parent Alphabet, with his investment bank's proper price targets ranging from $220 to $235, as an example, despite this man especially mentioned Google earnings at CNBC as "most controversial" tech earnings just a few days before the business indicators come out. Important pieces of Q3 earnings' puzzle stack up together perfectly last night for Google. Alphabet's core advertising business revenue added 10.4% YoY after climbing from $59.65 billion to $65.85 billion. Its most disputable YouTube component rose by even stronger 12.2% against $7.95 in the same period of 2023 to reach $8.92 billion vs $8.66 billion in Q2 and $8.10 billion in Q1. Besides, Google cloud division really outdone itself this time, even though it always shows impeccable form, as the firm's cloud sales suddenly got better condition to a whole billion of Dollars to jump from $10.35 billion in the previous quarter to $11.35 billion (+9.6% QoQ), compared to $8.41 billion in Q3 2023, performing at +35% YoY. These amazing contributions naturally resulted in smashing historical records on both the top and bottom lines of the report. An indication of $2.12 in terms of earnings per share, on total revenue of $88.27 billion, was 15% better than consensus expectations at $1.84 per share, while $1.89 per share was previously the best quarterly achievement for the search giant.

Google earnings predates four more quarterly releases of Wall Street’s “Magnificent Seven”, which would be delivered by Meta Platforms and Microsoft after the regular market's finish today, followed by Apple and Amazon tomorrow night. I have my stakes in all the four giants, though a smaller size in Microsoft, a bigger size in Meta and Amazon and a middle-size in Apple, as I have a good feeling concerning this tech earnings season among its flagship firms.

4742
115

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors